Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

201 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A new ELISA assay for diagnosis of acquired von Willebrand syndrome.
Siaka C, Rugeri L, Caron C, Goudemand J. Siaka C, et al. Haemophilia. 2003 May;9(3):303-8. doi: 10.1046/j.1365-2516.2003.00750.x. Haemophilia. 2003. PMID: 12694522
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.
Volkers P, Hanschmann KM, Calvez T, Chambost H, Collins PW, Demiguel V, Hart DP, Hay CRM, Goudemand J, Ljung R, Palmer BP, Santagostino E, van Hardeveld EM, van den Berg M, Keller-Stanislawski B. Volkers P, et al. Among authors: goudemand j. Haemophilia. 2019 May;25(3):398-407. doi: 10.1111/hae.13747. Epub 2019 May 7. Haemophilia. 2019. PMID: 31066174 Review.
Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra® ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP).
Susen S, Gruel Y, Godier A, Harroche A, Chambost H, Lasne D, Rauch A, Roullet S, Fontana P, Goudemand J, de Maistre E, Chamouard V, Wibaut B, Albaladejo P, Négrier C. Susen S, et al. Among authors: goudemand j. Haemophilia. 2019 Sep;25(5):731-737. doi: 10.1111/hae.13817. Epub 2019 Jul 11. Haemophilia. 2019. PMID: 31294904 Review.
Rituximab in postpartum-related acquired hemophilia.
Maillard H, Launay D, Hachulla E, Goudemand J, Lambert M, Morell-Dubois S, Queyrel V, Hatron PY. Maillard H, et al. Am J Med. 2006 Jan;119(1):86-8. doi: 10.1016/j.amjmed.2005.06.068. Am J Med. 2006. PMID: 16431202 No abstract available.
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.
Goudemand J, Rothschild C, Demiguel V, Vinciguerrat C, Lambert T, Chambost H, Borel-Derlon A, Claeyssens S, Laurian Y, Calvez T; FVIII-LFB and Recombinant FVIII study groups. Goudemand J, et al. Blood. 2006 Jan 1;107(1):46-51. doi: 10.1182/blood-2005-04-1371. Epub 2005 Sep 15. Blood. 2006. PMID: 16166584 Clinical Trial.
[Acquired hemophilia: current diagnostic and therapeutic approaches].
Lévesque H, Borg JY, Bossi P, Goudemand J, Guillet B, Cabane J. Lévesque H, et al. Rev Med Interne. 2001 Sep;22(9):854-66. doi: 10.1016/s0248-8663(01)00436-2. Rev Med Interne. 2001. PMID: 11599187 Review. French.
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients.
Borel-Derlon A, Federici AB, Roussel-Robert V, Goudemand J, Lee CA, Scharrer I, Rothschild C, Berntorp E, Henriet C, Tellier Z, Bridey F, Mannucci PM. Borel-Derlon A, et al. J Thromb Haemost. 2007 Jun;5(6):1115-24. doi: 10.1111/j.1538-7836.2007.02562.x. J Thromb Haemost. 2007. PMID: 17403090 Clinical Trial.
Response to Wiewel-Verschueren S et al.: gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review.
de Raucourt E, Bauduer F, Goudemand J. de Raucourt E, et al. Haemophilia. 2016 Sep;22(5):e435-6. doi: 10.1111/hae.13036. Epub 2016 Aug 3. Haemophilia. 2016. PMID: 27486008 No abstract available.
Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.
Bauduer F, de Raucourt E, Boyer-Neumann C, Trossaert M, Beurrier P, Faradji A, Peynet J, Borg JY, Chamouni P, Chatelanaz C, Henriet C, Bridey F, Goudemand J; French Postmarketing Study Group. Bauduer F, et al. Haemophilia. 2015 Jul;21(4):481-9. doi: 10.1111/hae.12655. Epub 2015 Mar 26. Haemophilia. 2015. PMID: 25817556 Free PMC article.
Compound heterozygosity or heterozygosity with two mutations in cis on the same allele? A rebuttal to the letter to the Editors: Koessler et al. Von Willebrand disease caused by compound heterozygosity for p.R854Q and p.R760C: diagnostic and therapeutic implications. Haemophilia 2011; 17: e240-2.
Veyradier A, Fressinaud E, Goudemand J. Veyradier A, et al. Haemophilia. 2011 Sep;17(5):e832-3. doi: 10.1111/j.1365-2516.2011.02531.x. Epub 2011 Apr 13. Haemophilia. 2011. PMID: 21489050 No abstract available.
201 results
Jump to page
Feedback